A European subsidiary of Harlan Laboratories, the US-based provider of contract-research services and research models, has appointed Invenium Pharmacology as its exclusive agent for contract research services in Australia, Southeast Asia and New Zealand.
Harlan Laboratories, Ltd, which provides general and specialty toxicology services to the pharmaceutical, chemical and agrochemical industries worldwide through its Contract Research Services (CRS) business, said the agreement “positions Harlan CRS for continued growth on a global scale”.
Anthony Bishop, managing director of Invenium Pharmacology will take on the primary contact role for Harlan CRS in Australia, Southeast Asia and New Zealand.
He brings to the task more than 15 years’ experience in business development, global project management and sales for pharmaceutical companies and contract research organisations.
“There are great growth opportunities for Harlan CRS in this region,” commented Ciriaco Maraschiello, director of strategic initiatives and drug discovery/translational medicine.
“Working with Anthony Bishop and Invenium Pharmacology, we can provide the expertise that companies and organizations in this region need – at a local level.”
Harlan Laboratories, Ltd is privately held, with headquarters in Itingen, Switzerland and laboratories in Germany, Spain, Switzerland and the UK.